It is a good investment to prevent the development of lifestyle diseases such as diabetes

2018-09-28T13:44:19+02:00March 31st, 2018|Categories: Endocrine, nutritional and metabolic diseases, Health Economics, Nordic Health Registers|

A poorly regulated diabetes patient is costly for both the public healthcare system and the private insurance companies. In a recent cost-effectiveness study of the LIVA platform ApHER concludes that there is a desirable investment return by managing diabetes patients digitally through online lifestyle coaching. Read the article at LIVA Healthcare here.